SSG
SVNT

Summit Securities Group’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Summit Securities Group’s Portfolio SVNT Stock Details SVNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-200
Closed – – 695
2013
Q4 		$0 Hold
200
– – ﹤0.01% 658
2013
Q3 		$0 Hold
200
– – ﹤0.01% 697
2013
Q2 		$0 Buy
+200
New +$139 ﹤0.01% 637

Summit Securities Group's SVNT Position: Q1 2014 in Review

Summit Securities Group sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q1 2014, closing a stake of 200 shares.

Summit Securities Group first reported a position in SVNT in Q2 2013 and held it in 3 quarters. The position peaked at $0 in Q4 2013. 2 funds tracked by Wall St. Rank hold SVNT as of Q1 2014.

  • Summit Securities Group reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q1 2014 after selling out during the quarter.
  • Summit Securities Group sold 200 SAVIENT PHARMACEUTICALS INC shares in Q1 2014.
  • Summit Securities Group first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 3 quarters.
  • Summit Securities Group's SAVIENT PHARMACEUTICALS INC position peaked at $0 in Q4 2013.
  • 2 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q1 2014.

Based on Summit Securities Group's 13F filing for Q1 2014, filed 17 Apr 2014.